Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients
Antoni Sicras-Mainar (Sicras-Mainar A), Ruth Navarro-Artieda (Navarro-Artieda R)
Diabetes Metab J. 2015;39(1):74-81.   Published online 2015 Feb 16     DOI: https://doi.org/10.4093/dmj.2015.39.1.74
Citations to this article as recorded by Crossref logo
Characteristics of Hypoglycemia Pateints Visiting the Emergency Department of a University Hospital
Sang-Hyeon Choi, Deok-Ki Youn, Moon-Gi Choi, Ohk-Hyun Ryu
The Journal of Korean Diabetes.2016; 17(3): 202.     CrossRef
Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J2015;39:74-81)
Antoni Sicras-Mainar, Ruth Navarro-Artieda
Diabetes & Metabolism Journal.2015; 39(2): 173.     CrossRef
Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
Wellington Santana da Silva Júnior, Amélio Fernando de Godoy-Matos, Luiz Guilherme Kraemer-Aguiar
BioMed Research International.2015; 2015: 1.     CrossRef
Letter: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J2015;39:74-81)
Hannah Seok
Diabetes & Metabolism Journal.2015; 39(2): 171.     CrossRef